| Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ... Infection, genetics and evolution 19, 337-348, 2013 | 426 | 2013 |
| HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ... Retrovirology 10, 1-13, 2013 | 191 | 2013 |
| A genomic signature and the identification of new sporulation genes AB Abecasis, M Serrano, R Alves, L Quintais, JB Pereira-Leal, ... Journal of bacteriology 195 (9), 2101-2115, 2013 | 150 | 2013 |
| Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form AB Abecasis, P Lemey, N Vidal, T de Oliveira, M Peeters, R Camacho, ... Journal of virology 81 (16), 8543-8551, 2007 | 133 | 2007 |
| Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution AB Abecasis, AM Vandamme, P Lemey Journal of virology 83 (24), 12917-12924, 2009 | 131 | 2009 |
| Phylogeography of dengue virus serotype 4, Brazil, 2010–2011 MRT Nunes, NR Faria, HB Vasconcelos, DB de Almeida Medeiros, ... Emerging infectious diseases 18 (11), 1858, 2012 | 113 | 2012 |
| Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G AB Abecasis, K Deforche, J Snoeck, LT Bacheler, P McKenna, ... Aids 19 (16), 1799-1806, 2005 | 105 | 2005 |
| A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes V Fonseca, PJK Libin, K Theys, NR Faria, MRT Nunes, MI Restovic, ... PLoS neglected tropical diseases 13 (5), e0007231, 2019 | 94 | 2019 |
| HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality AM Tavares, I Fronteira, I Couto, D Machado, M Viveiros, AB Abecasis, ... PloS one 12 (9), e0185526, 2017 | 86 | 2017 |
| Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG AB Abecasis, K Deforche, LT Bacheler, P McKenna, AP Carvalho, ... Antiviral therapy 11 (5), 581-589, 2006 | 84 | 2006 |
| Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable C Mavian, SK Pond, S Marini, BR Magalis, AM Vandamme, S Dellicour, ... Proceedings of the National Academy of Sciences 117 (23), 12522-12523, 2020 | 83 | 2020 |
| Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon NR Faria, MA Suchard, A Abecasis, JD Sousa, N Ndembi, I Bonfim, ... Infection, Genetics and Evolution 12 (2), 453-460, 2012 | 71 | 2012 |
| VIRULIGN: fast codon-correct alignment and annotation of viral genomes PJK Libin, K Deforche, AB Abecasis, K Theys Bioinformatics 35 (10), 1763-1765, 2019 | 67 | 2019 |
| Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ... BMC Infectious Diseases 14, 1-12, 2014 | 63 | 2014 |
| The impact of HIV-1 within-host evolution on transmission dynamics K Theys, P Libin, AC Pineda-Pena, A Nowe, AM Vandamme, AB Abecasis Current opinion in virology 28, 92-101, 2018 | 58 | 2018 |
| Patterns of transmitted HIV drug resistance in Europe vary by risk group D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L Jørgensen, ... PloS one 9 (4), e94495, 2014 | 54 | 2014 |
| Limited cross-border infections in patients newly diagnosed with HIV in Europe D Frentz, AMJ Wensing, J Albert, D Paraskevis, AB Abecasis, O Hamouda, ... Retrovirology 10, 1-10, 2013 | 53 | 2013 |
| Phylogenetic analysis as a forensic tool in HIV transmission investigations AB Abecasis, M Pingarilho, AM Vandamme Aids 32 (5), 543-554, 2018 | 50 | 2018 |
| HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir K Theys, J Vercauteren, J Snoeck, M Zazzi, RJ Camacho, C Torti, ... Antimicrobial agents and chemotherapy 57 (2), 1053-1056, 2013 | 50 | 2013 |
| Science in court: the myth of HIV fingerprinting AB Abecasis, AM Geretti, J Albert, L Power, M Weait, AM Vandamme The Lancet Infectious Diseases 11 (2), 78-79, 2011 | 45 | 2011 |
Anne-Mieke VandammeFull professor, KU Leuven, Belgium確認したメール アドレス: uzleuven.be
